BEAM Beam Therapeutics Inc
Company Analysis
Latest News
🔴 Beam Therapeutics is trading 4.1% down today as biotech sector sell-off continues
Beam Therapeutics is trading 4.1% down at $31.33 as the broader biotech sector faces pressure from profit-taking and risk-off sentiment. • The decline...
🔴 Beam Therapeutics is trading 10.0% down
Beam Therapeutics is trading at $32.22, down 10.0% from a comparison close of $35.82 during regular trading. This is a price-action follow-up, so a separate...
🔴 Beam Therapeutics is trading 5.2% down today following arbitration loss to Prime Medicine
Beam Therapeutics is trading 5.2% down at $33.97 today, primarily impacted by an arbitration tribunal's decision in favor of Prime Medicine regarding their...
🟢 Beam Therapeutics is trading 4.11% up today following FDA clearance for BEAM-304 and positive clinical data
Beam Therapeutics is trading at $37.29 (+4.11%) following recent FDA clearance for BEAM-304 and positive clinical data for BEAM-302. • The company recently...
🔴 BEAM is trading 5.8% down today as investors react to arbitration resolution and profit-taking
• BEAM is trading at $35.71 (-5.83%) as the stock pulls back following a significant rally driven by positive clinical data. • The decline follows a sharp...
🔴 BEAM is trading 4% down today on profit-taking after its BEAM-302 data rally
BEAM is trading 4% down at $36.40 as the stock undergoes a pre-market pullback following a sharp rally driven by positive clinical results. • The recent gains...
🟢 BEAM is trading 4.5% up today on positive Phase 1/2 data for its BEAM-302 program
BEAM is trading 4.5% up at $36.91 after investors reacted positively to new Phase 1/2 data for its BEAM-302 base-editing program in alpha-1 antitrypsin...
🟢 BEAM is trading 4.4% up today after promising BEAM-302 clinical data and broader biotech gains
BEAM is trading at $36.87 (4.39% up) after reporting promising Phase 1/2 clinical data for its BEAM-302 gene-editing program. • The study demonstrated...
🟢 BEAM extends move to 5.3% up
BEAM is trading at $35.26, up 5.3% versus the comparison close of $33.48 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 BEAM is trading 4.2% up today with no clear company-specific catalyst
BEAM is trading 4.2% up now at $34.87 after a recent multi-day pullback and sector-driven weakness. There are no fresh company-specific headlines, earnings, or...
🔴 BEAM is trading 4.02% down today amid broader biotech weakness and technical mean reversion
BEAM is trading at $32.94 (down 4.02%) as the stock continues its recent pullback amid a broader risk-off tone in the biotech sector and a slightly lower...
🟢 BEAM is trading 4.3% up today as it recovers from its recent pullback
BEAM is trading at $35.80 (+4.31%) after hours, reversing part of its June 30 pullback despite no major company-specific announcements, earnings releases, or...
🟢 BEAM is trading 4.9% up today on breakout momentum and broader market strength
BEAM is trading 4.93% up now at $36.52 as it extends a strong upward run driven by continued buying pressure and broader risk-on sentiment. • The move appears...
🟢 BEAM extends move to 5.4% up
BEAM is trading at $35.75, up 5.4% versus the comparison close of $33.93 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 BEAM surges 4.7% following recent FDA clearance for BEAM-304 gene-editing trial
Beam Therapeutics (BEAM) is trading 4.7% up today at $35.53. This follows recent positive developments for its gene-editing pipeline: * The U.S. FDA...
🟢 Beam Therapeutics Inc is trading 4.22% up
BEAM is trading at $35.33, up 4.22%.
🟢 BEAM is trading 4.1% up today extending a multi-day rebound on positive BEAM-302 trial data momentum
BEAM is trading at $35.28 (4.1% up), extending a strong multi-day rebound from last week’s pullback as momentum continues to build. • Investors are continuing...
🟢 BEAM extends move to 6.9% up
BEAM is trading at $35.50, up 6.9% versus the comparison close of $33.20 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 BEAM is trading 4% up today as it rebounds from yesterday's sharp drop
BEAM is trading 4% up at $34.54 as the stock stages a partial recovery following yesterday’s significant decline. • The move follows a 6.6% drop in the...
🔴 BEAM extends move to 5.1% down
BEAM is trading at $33.71, down 5.1% versus the comparison close of $35.53 during regular trading. This is a price-movement alert; no separate company-specific...